journal article Open Access Dec 30, 2023

Analysis of Hand Function, Upper Limb Disability, and Its Relationship with Peripheral Vascular Alterations in Raynaud’s Phenomenon

Diagnostics Vol. 14 No. 1 pp. 93 · MDPI AG
View at Publisher Save 10.3390/diagnostics14010093
Abstract
This study aimed to compare vascular involvement, hand functionality, and upper limb disability between Raynaud’s phenomenon participants and controls. Also, we analyzed the relationships between vascular impairment, mobility, and strength with disability in this Raynaud population. We conducted a case–control study with fifty-seven participants. We registered sociodemographic and clinical data; vascular variables (temperature, cold test, blood flow, and oxygen saturation); functional variables (pinch strength, range of motion), and disability (Shortened Disabilities of the Arm, Shoulder and Hand Questionnaire) (Q-DASH). Raynaud participants present more disability in all Q-DASH subscales, lower hands’ temperature pre and post cold test, decreased blood flow on radial artery, decreased ranges of motions at passive extension of index finger, and active flexion and extension of thumb than the healthy controls. The multivariate regression analysis showed that extension of the index finger, lateral pinch strength, and oxygen saturation were significantly associated with disability in RP, almost the 55% of the total variance on the upper limb, 27% at sports/arts, and 42% at work. Our findings suggest that RP has a disabling effect on the upper extremities and a practice of activities in people who suffer it. Also, disability in Raynaud seems to be more related with hand mobility and strength impairment than vascular injury.
Topics

No keywords indexed for this article. Browse by subject →

References
48
[1]
Maverakis "International consensus criteria for the diagnosis of Raynaud’s phenomenon" J. Autoimmun. (2014) 10.1016/j.jaut.2014.01.020
[2]
Prete "Raynaud’s phenomenon: From molecular pathogenesis to therapy" Autoimmun. Rev. (2014) 10.1016/j.autrev.2013.12.001
[3]
Salaffi "Health-related quality of life in primary Raynaud phenomenon" J. Clin. Rheumatol. (2008) 10.1097/rhu.0b013e31817a2485
[4]
Goundry "Diagnosis and management of Raynaud’s phenomenon" BMJ (2012) 10.1136/bmj.e289
[5]
Kadan "How Can Follow-Up of Patients with Raynaud Phenomenon be Optimized?" Med. Sci. Monit Basic Res. (2015) 10.12659/msmbr.893998
[6]
Hughes "Raynaud’s phenomenon" Best Pract. Res. Clin. Rheumatol. (2016) 10.1016/j.berh.2016.04.001
[7]
Norimatsu "Expert-Level Distinction of Systemic Sclerosis from Hand Photographs Using Deep Convolutional Neural Networks" J. Investig. Dermatol. (2021) 10.1016/j.jid.2021.03.020
[8]
Belch "ESVM guidelines-the diagnosis and management of Raynaud’s phenomenon" Vasa (2017) 10.1024/0301-1526/a000661
[9]
Herrick "New Perspectives in the Imaging of Raynaud’s Phenomenon" Eur. J. Rheumatol. (2020) 10.5152/eurjrheum.2020.19124
[10]
Daniels "Behaviour change interventions for the management of Raynaud’s phenomenon: A systematic review protocol" BMJ Open (2017) 10.1136/bmjopen-2017-017039
[11]
Sandqvist "Raynaud’s phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosis" Scand. J. Rheumatol. (2018) 10.1080/03009742.2017.1350745
[12]
Hirschl "Low level laser therapy in primary Raynaud’s phenomenon–results of a placebo controlled, double blind intervention study" J. Rheumatol. (2004)
[13]
Hughes "Prediction and impact of attacks of Raynaud’s phenomenon, as judged by patient perception" Rheumatology (2015) 10.1093/rheumatology/kev002
[14]
Merkel "Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon" Arthritis Rheum. (2002) 10.1002/art.10486
[15]
Giurgea "Relationship of Age and Body Mass Index to Skin Temperature and Skin Perfusion in Primary Raynaud’s Phenomenon" Arthritis Rheumatol. (2015) 10.1002/art.38923
[16]
Medsger "Raynaud’s phenomenon: A proposal for classification" Clin. Exp. Rheumatol. (1992)
[17]
Grossi "Functional infrared imaging of paroxysmal ischemic events in patients with Raynaud’s phenomenon" Int. J. Immunopathol. Pharmacol. (2010) 10.1177/039463201002300225
[18]
Ismail "Differential diagnosis of Raynaud’s phenomenon based on modeling of finger thermoregulation" Physiol. Meas. (2014) 10.1088/0967-3334/35/4/703
[19]
Plana "Pulse oximetry screening for critical congenital heart defects" Cochrane Database Syst. Rev. (2017)
[20]
Akdogan "Effect of capillaroscopic patterns on the pulse oximetry measurements in systemic sclerosis patients" Microvasc. Res. (2015) 10.1016/j.mvr.2014.02.002
[21]
Toprak "Dynamic Doppler evaluation of the hand arteries of the patients with Raynaud’s disease" Clin. Rheumatol. (2009) 10.1007/s10067-009-1131-1
[22]
Navarro "Spanish version of the DASH questionnaire. Cross-cultural adaptation, reliability, validity and responsiveness" Med. Clin. (2006)
[23]
The shortened disabilities of the arm, shoulder and hand questionnaire (Quick DASH): validity and reliability based on responses within the full-length DASH

Christina Gummesson, Michael M Ward, Isam Atroshi

BMC Musculoskeletal Disorders 2006 10.1186/1471-2474-7-44
[24]
Bain "The functional range of motion of the finger joints" J. Hand Surg. Eur. (2015) 10.1177/1753193414533754
[25]
Engstrand "Interrater reliability in finger joint goniometer measurement in Dupuytrens disease" Am. J. Occup. Ther. (2012) 10.5014/ajot.2012.001925
[26]
Carey "Reliability, validity, and clinical usability of a digital goniometer" Work (2010) 10.3233/wor-2010-1007
[27]
Carvalho "Analysis of the reliability and reproducibility of goniometry compared to hand photogrammetry" Acta Ortop. Bras. (2012) 10.1590/s1413-78522012000300003
[28]
"Influence of upper limb disability, manual dexterity and fine motor skill on general self-efficacy in institutionalized elderly with osteoarthritis" J. Hand Ther. (2016) 10.1016/j.jht.2015.12.001
[29]
Reliability and validity of grip and pinch strength evaluations

Virgil Mathiowetz, Karen Weber, Gloria Volland et al.

The Journal of Hand Surgery 1984 10.1016/s0363-5023(84)80146-x
[30]
Fess, E.E., and Moran, C.A. (1981). Clinical Assessment Recommendations, American Society of Hand Therapists.
[32]
Taylor "Measurement of cold challenge responses in primary Raynaud’s phenomenon and Raynaud’s phenomenon associated with systemic sclerosis" Ann. Rheum. Dis. (1992) 10.1136/ard.51.11.1193
[33]
Roustit "Impaired transient vasodilation and increased vasoconstriction to digital local cooling in primary Raynaud’s phenomenon" Am. J. Physiol. Heart Circ. Physiol. (2011) 10.1152/ajpheart.00246.2011
[34]
Brown "The effects of stress, anxiety, and outdoor temperature on the frequency and severity of Raynaud’s attacks: The Raynaud’s Treatment Study" J. Behav. Med. (2001) 10.1023/a:1010758530555
[35]
Stoyneva "Laser Doppler-recorded venoarteriolar reflex in Raynaud’s phenomenon" Auton. Neurosci. (2004) 10.1016/j.autneu.2004.08.012
[36]
Mirbod "A non-invasive technique for the evaluation of peripheral circulatory functions in female subjects with Raynaud’s phenomenon" Ind. Health (2017) 10.2486/indhealth.2016-0201
[37]
Roustit "Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis" Microvasc. Res. (2014) 10.1016/j.mvr.2014.05.007
[38]
Maga, P., Henry, B.M., Kmiotek, E.K., Gregorczyk-Maga, I., Kaczmarczyk, P., Tomaszewski, K.A., and Niżankowski, R. (2016). Postocclusive Hyperemia Measured with Laser Doppler Flowmetry and Transcutaneous Oxygen Tension in the Diagnosis of Primary Raynaud’s Phenomenon: A Prospective, Controlled Study. BioMed Res. Int., 2016. 10.1155/2016/9645705
[39]
Bello "The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud’s Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" Arthritis Rheumatol. (2017) 10.1002/art.40123
[40]
Seror "Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements" Rheumatology (2017) 10.1093/rheumatology/kex157
[41]
Uppal "A prospective study of the use of botulinum toxin injections in the treatment of Raynaud’s syndrome associated with scleroderma" J. Hand Surg. Eur. (2014) 10.1177/1753193413516242
[42]
Landim "The evaluation of a home-based program for hands in patients with systemic sclerosis" J. Hand Ther. (2017)
[43]
Sandqvist "A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis" Scand. J. Rheumatol. (2009) 10.1080/03009740802695466
[44]
Mason "Upper limb disability in HAVS cases–how does it relate to the neurosensory or vascular elements of HAVS?" Occup. Med. (2005) 10.1093/occmed/kqi076
[45]
Seror "Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers" Arthritis Care Res. (2011) 10.1002/acr.20342
[46]
Roh "Comparative study on the effectiveness of a corticosteroid injection for carpal tunnel syndrome in patients with and without Raynaud’s phenomenon" Bone Jt. J. (2017) 10.1302/0301-620x.99b12.bjj-2017-0371.r2
[47]
Palmer "The clinical grading of Raynaud’s phenomenon and vibration-induced white finger: Relationship between finger blanching and difficulties in using the upper limb" Int. Arch. Occup. Environ. Health (2002) 10.1007/s004200100275
[48]
Anderson "Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging—A non-invasive technique by which to measure microvascular dysfunction in Raynaud’s phenomenon" Rheumatology (2004) 10.1093/rheumatology/keh244
Metrics
2
Citations
48
References
Details
Published
Dec 30, 2023
Vol/Issue
14(1)
Pages
93
License
View
Cite This Article
Rosa Mª Tapia-Haro, Ma Carmen García-Ríos, Adelaida Mª Castro-Sánchez, et al. (2023). Analysis of Hand Function, Upper Limb Disability, and Its Relationship with Peripheral Vascular Alterations in Raynaud’s Phenomenon. Diagnostics, 14(1), 93. https://doi.org/10.3390/diagnostics14010093